?
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | |||||
1. Identity of the issuer or the underlying issuer | Immunodiagnostic Systems | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | ü | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to the | Schroders plc | ||||
4. Full name of shareholder(s) | |||||
5. Date of the transaction and date on | 02.09.12 | ||||
6. Date on which issuer notified: | 03.09.12 | ||||
7. Threshold(s) that is/are crossed or | Above 10% |
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type of
|
Situation previous | Resulting situation after the triggering transaction | ||||||||||||||
Number |
Number |
Number |
Number of voting | % of voting rights | ||||||||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
Ordinary | 2,756,904 | 1,939,010 | 3,502,718 | N/A | 3,013,718 | N/A | 10.423 | |||||||||
GB00B01YZ052 | ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial | Exercise price | Expiration date |
Exercise/ | Number of voting rights instrument refers to | % of voting rights | |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
3,013,718 | 10.423 |
9. Chain of controlled undertakings through which the voting rights and/or the | ||
Cazenove Capital Management Ltd 8,050 shares 0.028% Schroder Investment Management Ltd 3,004,319 shares 10.390% Schroder Investment Management North America Ltd 1,349 shares 0.005% | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease | ||
12. Date on which proxy holder will cease to hold | ||
|
The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. | |
14. Contact name: | Laura Whelan | |
15. Contact telephone number: | 0207 658 6000 |
This information is provided by RNS
distributed by |